{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:04:25Z","timestamp":1773450265540,"version":"3.50.1"},"reference-count":34,"publisher":"American Association of Avian Pathologists (AAAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avian Diseases"],"published-print":{"date-parts":[[2022,2,11]]},"DOI":"10.1637\/21-00089","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T09:47:18Z","timestamp":1645177638000},"source":"Crossref","is-referenced-by-count":5,"title":["Vaccinal Efficacy of Recombinant Marek's Disease Vaccine 301B\/1 Expressing Chicken Interleukin-15"],"prefix":"10.1637","volume":"66","author":[{"given":"Taejoong","family":"Kim","sequence":"first","affiliation":[{"name":"Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, Athens, GA 30605"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cari","family":"Hearn","sequence":"additional","affiliation":[{"name":"Avian Diseases and Oncology Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 4279 E. Mt. Hope Road, East Lansing, MI 48823"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1212","reference":[{"key":"21","doi-asserted-by":"crossref","unstructured":"BK Tischer, J von Einem, B Kaufer, et al.  \"Biotechniques.\"  40, \"Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli.\" 191 (2006)","DOI":"10.2144\/000112096"},{"key":"8","doi-asserted-by":"crossref","unstructured":"KA. Schat,  \"Avian Dis.\"  60, \"History of the first generation Marek's disease vaccines: the science and little-known facts.\" 715 (2016)","DOI":"10.1637\/11429-050216-Hist"},{"key":"5","doi-asserted-by":"crossref","unstructured":"RL. Witter,  \"Avian Dis.\"  31, \"New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: comparative efficacy.\" 752 (1987)","DOI":"10.2307\/1591027"},{"key":"6","doi-asserted-by":"crossref","unstructured":"RL Witter, RF Silva, LF Lee,  \"Avian Dis.\"  31, \"New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: selected biological and molecular characteristics.\" 829 (1987)","DOI":"10.2307\/1591039"},{"key":"7","doi-asserted-by":"crossref","unstructured":"RL. Witter,  \"Avian Dis.\"  41, \"Increased virulence of Marek's disease virus field isolates.\" 149 (1997)","DOI":"10.2307\/1592455"},{"key":"3","doi-asserted-by":"crossref","unstructured":"N Boodhoo, A Gurung, S Sharif, et al.  \"Vet. Res.\"  47, \"Marek's disease in chickens: a review with focus on immunology.\" 119 (2016)","DOI":"10.1186\/s13567-016-0404-3"},{"key":"1","doi-asserted-by":"crossref","unstructured":"PM. Biggs,  \"Current Topics in Microbiology and Immunology.\"  \"The history and biology of Marek's disease virus.\" 1 (2001)","DOI":"10.1007\/978-3-642-56863-3_1"},{"key":"2","unstructured":"KA Schat  and V Nair  \"Diseases of poultry.\"  \"Marek's disease.\" 515 (2013)"},{"key":"4","doi-asserted-by":"crossref","unstructured":"NM Faiz, AL Cortes, JS Guy, et al.  \"Avian Pathol.\"  46, \"Evaluation of factors influencing the development of late Marek's disease virus-induced immunosuppression: virus pathotype and host sex.\" 376 (2017)","DOI":"10.1080\/03079457.2017.1290214"},{"key":"9","doi-asserted-by":"crossref","unstructured":"M Bublot  and J Sharma  \"Marek's disease: an evolving problem. Biology of Animal Infections.\"  \"Vaccination against Marek's disease.\" 168 (2004)","DOI":"10.1016\/B978-012088379-0\/50017-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"DW White, R Suzanne Beard, ES Barton,  \"Immunol Rev.\"  245, \"Immune modulation during latent herpesvirus infection.\" 189 (2012)","DOI":"10.1111\/j.1600-065X.2011.01074.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"PJ Hanley  and CM Bollard  \"Viruses.\"  6, \"Controlling cytomegalovirus: helping the immune system take the lead.\" 2242 (2014)","DOI":"10.3390\/v6062242"},{"key":"12","unstructured":"JM Sharma  and RL Witter  \"Cancer Res.\"  35, \"The effect of B-cell immunosuppression on age-related resistance of chickens to Marek's disease.\" 711 (1975)"},{"key":"13","doi-asserted-by":"crossref","unstructured":"S Umthong, JR Dunn, HH Cheng,  \"Vaccines.\"  8, \"Depletion of CD8\u03b1\u03b2+ T cells in chickens demonstrates their involvement in protective immunity towards Marek's disease with respect to tumor incidence and vaccinal protection.\" 557 (2020)","DOI":"10.3390\/vaccines8040557"},{"key":"14","doi-asserted-by":"crossref","unstructured":"PY Perera, JH Lichy, TA Waldmann, et al.  \"Microbes Infect.\"  14, \"The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.\" 247 (2012)","DOI":"10.1016\/j.micinf.2011.10.006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"MG Tovey  and C Lallemand  \"Methods Mol. Biol.\"  626, \"Adjuvant activity of cytokines.\" 287 (2010)","DOI":"10.1007\/978-1-60761-585-9_19"},{"key":"16","doi-asserted-by":"crossref","unstructured":"X Xu, Q Sun, X Yu, et al.  \"Virus Res.\"  233, \"Rescue of nonlytic Newcastle disease virus (NDV) expressing IL-15 for cancer immunotherapy.\" 35 (2017)","DOI":"10.1016\/j.virusres.2017.03.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"SA Valkenburg, OT Li, PW Mak, et al.  \"Proc. Natl. Acad. Sci.\"  111, \"IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection.\" 5676 (2014)","DOI":"10.1073\/pnas.1403684111"},{"key":"18","doi-asserted-by":"crossref","unstructured":"K Hock, J Laengle, I Kuznetsova, et al.  \"Surgery.\"  161, \"Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in vivo.\" 735 (2017)","DOI":"10.1016\/j.surg.2016.08.045"},{"key":"19","doi-asserted-by":"crossref","unstructured":"T Kim, SJ Spatz, JR Dunn,  \"J. Gen. Virol.\"  101, \"Vaccinal efficacy of molecularly cloned Gallid alphaherpesvirus 3 strain 301B\/1 against very virulent Marek's disease virus challenge.\" 542 (2020)","DOI":"10.1099\/jgv.0.001403"},{"key":"20","doi-asserted-by":"crossref","unstructured":"R Hernandez  and DT Brown  \"Curr. Protoc. Microbiol.\"  17, \"Growth and maintenance of chick embryo fibroblasts (CEF).\" A.4I.1 (2010)","DOI":"10.1002\/9780471729259.mca04is17"},{"key":"22","doi-asserted-by":"crossref","unstructured":"M Niikura, T Kim, RF Silva, et al.  \"J. Gen. Virol.\"  92, \"Virulent Marek's disease virus generated from infectious bacterial artificial chromosome clones with complete DNA sequence and the implication of viral genetic homogeneity in pathogenesis.\" 598 (2011)","DOI":"10.1099\/vir.0.026864-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"W Min, HS Lillehoj, G Li, et al.  \"Vet. Immunol. Immunopathol.\"  88, \"Development and characterization of monoclonal antibodies to chicken interleukin-15.\" 49 (2002)","DOI":"10.1016\/S0165-2427(02)00123-X"},{"key":"24","unstructured":"\"JAMOVI, version 1.6.\"  (2021)"},{"key":"25","unstructured":"\"Geneious Prime, version 2019.2.3. Geneious.\"  (2019)"},{"key":"26","doi-asserted-by":"crossref","unstructured":"K Haq, I Elawadli, P Parvizi, et al.  \"Antiviral Res.\"  90, \"Interferon-gamma influences immunity elicited by vaccines against very virulent Marek's disease virus.\" 218 (2011)","DOI":"10.1016\/j.antiviral.2011.04.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Z Xing  and KA Schat  \"J. Virol.\"  74, \"Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus.\" 3605 (2000)","DOI":"10.1128\/JVI.74.8.3605-3612.2000"},{"key":"28","doi-asserted-by":"crossref","unstructured":"MF Abdul-Careem, DB Hunter, S Shanmuganathan, et al.  \"Vet. Immunol. Immunopathol.\"  126, \"Cellular and cytokine responses in feathers of chickens vaccinated against Marek's disease.\" 362 (2008)","DOI":"10.1016\/j.vetimm.2008.07.003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"ED Heller  and KA Schat  \"Avian Pathol.\"  16, \"Enhancement of natural killer cell activity by Marek's disease vaccines.\" 51 (1987)","DOI":"10.1080\/03079458708436352"},{"key":"30","doi-asserted-by":"crossref","unstructured":"S Umthong, JR Dunn, HH Cheng,  \"Vaccine.\"  37, \"Towards a mechanistic understanding of the synergistic response induced by bivalent Marek's disease vaccines to prevent lymphomas.\" 6397 (2019)","DOI":"10.1016\/j.vaccine.2019.09.003"},{"key":"31","doi-asserted-by":"crossref","unstructured":"HS Lillehoj, X Ding, MA Quiroz, et al.  \"Avian Dis.\"  49, \"Resistance to intestinal coccidiosis following DNA immunization with the cloned 3-1E Eimeria gene plus IL-2, IL-15, and IFN-gamma.\" 112 (2005)","DOI":"10.1637\/7249-073004R"},{"key":"32","doi-asserted-by":"crossref","unstructured":"D Ma, C Ma, L Pan, et al.  \"Exp. Parasitol.\"  127, \"Vaccination of chickens with DNA vaccine encoding Eimeria acervulina 3-1E and chicken IL-15 offers protection against homologous challenge.\" 208 (2011)","DOI":"10.1016\/j.exppara.2010.07.015"},{"key":"33","doi-asserted-by":"crossref","unstructured":"KL Lim, SD Jazayeri, SK Yeap, et al.  \"BMC Vet. Res.\"  8, \"Co-administration of avian influenza virus H5 plasmid DNA with chicken IL-15 and IL-18 enhanced chickens immune responses.\" 132 (2012)","DOI":"10.1186\/1746-6148-8-132"},{"key":"34","doi-asserted-by":"crossref","unstructured":"KL Lim, SD Jazayeri, SK Yeap, et al.  \"Res. Vet. Sci.\"  95, \"Antibody and T cell responses induced in chickens immunized with avian influenza virus N1 and NP DNA vaccine with chicken IL-15 and IL-18.\" 1224 (2013)","DOI":"10.1016\/j.rvsc.2013.07.013"}],"container-title":["Avian Diseases"],"original-title":[],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T19:53:57Z","timestamp":1649361237000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-66\/issue-1\/21-00089\/Vaccinal-Efficacy-of-Recombinant-Mareks-Disease-Vaccine-301B-1-Expressing\/10.1637\/21-00089.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1637\/21-00089","relation":{},"ISSN":["0005-2086"],"issn-type":[{"value":"0005-2086","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,11]]}}}